Covaxin trials for kids likely soon in Nagpur

Bharat Biotech, makers of indigenous Covid-19 vaccine Covaxin, is expected to start vaccine trial for children by February-end or early March this year. As per international regulations, only vaccines based on inactivated virus can be administered to children under 16 years. Hence, Covaxin is the only suitable option for children in India, as the others are based on mRNA and chimpanzee adenovirus vector platforms.